All In Biotech

Drug Trial Radar · NCT01923194

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females

A Randomized, Assessor-blinded, Parallel Group, Multi-center, Non-inferiority Study Investigating the Efficacy and Safety of Highly Purified Urofollitropin for Injection Compared to Recombinant Human Follitropin Alfa for Injection for Ovulation Induction Using a Low-dose, Step-up Protocol in Chinese Females With WHO Group II Anovulatory Infertility Failing to Conceive on Clomiphene Citrate

Last checked: Nov 20, 2026Latest source record: Aug 21, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 215 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

215

Actual

Start

Oct 2013

Primary completion

Jul 2015

Study completion Aug 2015

Sponsor

Lead sponsor
Ferring PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 15, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 20 years, up to 39 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate the Efficacy and Safety of Highly Purified Urofollitropin for Injection Compared to Recombinant Human Follitropin Alfa for Injection for Ovulation Induction in Chinese females

Conditions

  • Anovulation

Interventions

  • Highly Purified UrofollitropinDrug

    for Injection

  • Recombinant Human Follitropin AlfaDrug

    for Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The ovulation rate defined as the percentage of subjects who present ovulationTime frame: From 6 days up to 7 weeks post hCG (human chorionic gonadotropin) administration

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Chinese PLA General Hospital

    Beijing, Beijing Municipality, China

  • Navy General Hospital

    Beijing, Beijing Municipality, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China

  • Peking University First Hospital

    Beijing, Beijing Municipality, China

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China

  • Sun Yat-sen Memorial Hospital Sun Yat-sen University

    Guangzhou, Guangdong, China

  • The Third Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • Tongji Hospital Tongji Medical College of HUST Tongji Medical College Huazhong University of Science & Technology

    Wuhan, Hubei, China

  • The First Affiliated Hospital with Nanjing Medical University

    Nanjing, Jiangsu, China

  • ShengJing Hospital of China Medical University

    Shenyang, Liaoning, China

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.